Switching to tenofovir alafenamide versus continued therapy in chronic hepatitis B patients who were treated with entecavir: A prospective, multicenter, randomized controlled study

Entecavir (ETV) and tenofovir alafenamide fumarate (TAF) have been used widely to treat patients with chronic hepatitis B virus (HBV) infection, but it is still unclear how best to use these drugs. Although some studies compared the efficacies of treatment switch from ETV to TAF, there has been no r...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Kosuke, Inoue, Jun, Akahane, Takehiro, Kobayashi, Tomoo, Sato, Shuichi, Kisara, Norihiro, Ninomiya, Masashi, Iwata, Tomoaki, Sano, Akitoshi, Tsuruoka, Mio, Onuki, Masazumi, Masamune, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524959/
https://www.ncbi.nlm.nih.gov/pubmed/36181074
http://dx.doi.org/10.1097/MD.0000000000030630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524959/
https://www.ncbi.nlm.nih.gov/pubmed/36181074
http://dx.doi.org/10.1097/MD.0000000000030630

Ejemplares similares